Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

tags : Disease    crawled time : 15:15    save search

Gilead to Present Data From Liver Disease Development Programs at The Liver Meeting®
Published: 2021-11-09 (Crawled : 15:15) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M twitter stocktwits trandingview |
Health Technology
| | O: 0.09% H: 0.0% C: 0.0%

disease liver disease liver
Clinical experts establish first-ever global consensus for the appropriate use of intravascular ultrasound (IVUS) in peripheral vascular disease interventions
Published: 2021-10-05 (Crawled : 15:15) - globenewswire.com
PHG | $19.98 0.0% 540K twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 1.14% C: 0.39%

disease
VectivBio Expands Rare Disease Pipeline with Comet Therapeutics Acquisition
Published: 2021-09-01 (Crawled : 15:15) - biospace.com/
ONON | $31.58 -4.33% -0.03% 3M twitter stocktwits trandingview |
Manufacturing
| Email alert Add to watchlist

disease acquisition therapeutics rare
Biologics Market Size to Reach USD 477.15 Billion in 2027 | Rapid Advancements in Molecular Therapy and Cell-Based Biologics, Increasing Incidence of Chronic Diseases, are Some Key Factors Driving Industry Growth, says Emergen Research
Published: 2021-07-29 (Crawled : 15:15) - prnewswire.com
NVO | News | $122.71 -0.03% 0.17% 5M twitter stocktwits trandingview |
Health Technology
| | O: 0.49% H: 0.26% C: -0.62%
JNJ | News | $147.91 1.49% -0.03% 9.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.33% H: 0.35% C: -0.32%
ABBV | $166.41 1.06% 0.0% 5.5M twitter stocktwits trandingview |
Health Technology
| | O: 0.4% H: 0.08% C: -0.13%
SNY | News | $46.32 2.05% 2.01% 3.3M twitter stocktwits trandingview |
Health Technology
| | O: -0.69% H: 0.08% C: -0.33%

disease therapy molecular growth research merge
Bionano Genomics Announces Back-to-Back Publications in the American Journal of Human Genetics that Compare Optical Genome Mapping to Traditional Methods for Structural Variant Analysis in Inherited Genetic Disease and Hematological Malignancies
Published: 2021-07-07 (Crawled : 15:15) - globenewswire.com
BNGO | $0.75 -4.73% -4.96% 980K twitter stocktwits trandingview |
Health Technology
| | O: -0.15% H: 0.0% C: -4.26%

disease genetic optical genomic
Multi-Site Contributor Headlands Research Congratulates Biogen on FDA Approval of Aducanumab for Alzheimer’s Disease
Published: 2021-06-16 (Crawled : 15:15) - biospace.com/
KKR | $92.62 -0.78% 0.0% 4.5M twitter stocktwits trandingview |
Finance
| | O: 0.66% H: 1.75% C: 1.73%

disease alzheimer fda fda approval research approval alzheimer’s alzheimer's disease alzheimer's
Insights on the Medical Electrodes Global Market to 2029 - Growing Elderly Population Coupled with Rising Prevalence of Chronic and Other Diseases is Driving Growth
Published: 2021-06-15 (Crawled : 15:15) - prnewswire.com
MDT | $79.48 0.37% -0.29% 6.7M twitter stocktwits trandingview |
Health Technology
| | O: 0.26% H: 0.71% C: 0.56%
CNMD | $72.64 2.2% 0.0% 500K twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.77% C: -0.19%
BSX | $67.33 -0.13% -0.31% 7M twitter stocktwits trandingview |
Health Technology
| | O: 0.38% H: 0.54% C: 0.12%
NTUS | $32.96 0.09% 0.0% twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.2% C: 2.2%
CNMD | $72.64 2.2% -1.98% 500K twitter stocktwits trandingview |
Health Technology
| | O: 0.04% H: 0.77% C: -0.19%

disease growing growth
Atara Biotherapeutics Presents Positive Tab-cel® Long-Term Overall Survival Data for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease After Solid Organ Transplant at ATC 2021 Virtual Connect
Published: 2021-06-07 (Crawled : 15:15) - biospace.com/
ATRA | $0.6755 -2.34% -2.4% 1.6M twitter stocktwits trandingview |
Health Technology
| | O: 0.15% H: 7.69% C: 6.52%

disease positive iot tab-cel cel
Vaxcyte Announces Publication of Preclinical Data Supporting the Potential of VAX-24 for the Prevention of Invasive Pneumococcal DiseaseVAX-24 is a 24-Valent Broad-Spectrum Pneumococcal Conjugate Vaccine Leveraging Vaxcyte’s Technology Platform
Published: 2021-05-10 (Crawled : 15:15) - biospace.com/
PCVX | $60.82 0.33% 0.33% 1.3M twitter stocktwits trandingview |
Health Technology
| | O: 3.12% H: 0.0% C: -9.57%
STRO | $3.635 -3.58% -3.71% 520K twitter stocktwits trandingview |
Health Technology
| | O: 1.45% H: 4.65% C: 2.45%

disease potential vaccine technology preclinical pre-clinical pneumococcal
Gainers vs Losers
67% 33%

Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M twitter stocktwits trandingview |
Finance

EGOX | $0.0515 43.06% 30.1% 330M twitter stocktwits trandingview |

OLB 4 | $0.33 -14.95% 25.53% 840K twitter stocktwits trandingview |
Technology Services

NVFY | $2.77 31.28% 23.83% 33M twitter stocktwits trandingview |
Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M twitter stocktwits trandingview |
Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M twitter stocktwits trandingview |
Distribution Services

INSG | $3.03 25.21% 20.13% 330K twitter stocktwits trandingview |
Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K twitter stocktwits trandingview |
Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M twitter stocktwits trandingview |

ASNS | $0.828 21.75% 17.86% 18K twitter stocktwits trandingview |


Your saved searches
Save your searches and get alerts when important news are released.